Ras undergoes post-translational modifications including farnesylation, proteolysis, and carboxymethylation at the C terminus, which are necessary for membrane recruitment and effector recognition. Full activation of c-Raf-1 requires cooperative interaction of the farnesylated C terminus and the activator region of Ras with its cysteine-rich domain (CRD). However, the molecular basis for this interaction remains unclear because of difficulties in preparing modified Ras in amounts sufficient for structural studies. Here, we use Sortase A-catalyzed protein ligation to prepare modified Ras in sufficient amounts for NMR and X-ray crystallographic analyses. The results show that the farnesylated C terminus establishes an intramolecular interaction with the catalytic domain and brings the farnesyl moiety to the proximity of the activator region, which may be responsible for their cooperative recognition of c-Raf-1-CRD.
grossly divided into two parts: the catalytic domain (Ras ) corresponding to the amino acid residues 1-166 and the hypervariable region (HVR) corresponding to the residues 167-189 in H-Ras, K-Ras4A and N-Ras (Fig. S1A) . Ras , whose amino acid sequence is highly conserved among the isoforms, harbors the guanine nucleotides and, in its GTP-bound form, associates with the Ras-binding domains (RBDs) of the effectors through its flexible binding interface composed of two regions, Switch I (residues [32] [33] [34] [35] [36] [37] [38] and Switch II (residues 60-75) [2] [3] [4] [5] . In addition, the residues 23-31 and 39-50 flanking Switch I are named the 'activator region' because they contain various substitutions in a Ras-homolog Rap1, which has an antagonistic effect toward Ras-dependent malignant transformation, and because introduction of Rap1-type substitutions into this region indeed abrogated the activity to activate c-Raf-1 [6] [7] [8] . On the other hand, the amino acid sequence of HVR is highly divergent except for the C-terminal CAAX motif (A, aliphatic amino acids; X, any amino acids), which is subjected to a series of post-translational modification reactions as follows [9] . As the first step, a farnesyl group is covalently attached to Cys186 in the CAAX motif by farnesyltransferase. This prenylation reaction is followed by proteolytic removal of the AAX tripeptide by Ras-converting enzyme-1 and subsequently by carboxymethylation of the resulting C-terminal Cys by isoprenylcysteine carboxymethytransferase-1. These modifications are essential for recruitment of Ras to the plasma membrane. In addition, a further modification step, where a palmitoyl group is attached to the Cys residues immediately upstream of the CAAX motif by palmitoyltransferase, stabilizes the membrane anchoring of farnesylated H-Ras, N-Ras, and K-Ras4A. We showed that the post-translational modifications, especially the farnesylation, of Ras, are necessary for the full activation of the effectors such as c-Raf-1 and yeast adenylyl cyclase [10, 11] . The Nterminal regulatory region of c-Raf-1 contains two domains responsible for the interaction with Ras, RBD (residues 51-131), and the cysteine-rich domain (CRD, residues 139-184) [12] (Fig. S1A) . RBD binds to the residues in Switch I with the K D value of 10 À7 -
10
À8 M order in a GTP-dependent manner, whose molecular basis was clarified by X-ray crystallography [3, 13, 14] . On the other hand, CRD binds to Ras in a manner independent of the nature of the guanine nucleotide, and this interaction is necessary for the full activation of c-Raf-1 [11, [15] [16] [17] [18] . We showed that the Ras-CRD interaction is dependent on the farnesylation of H-Ras and abolished by substitutions, such as N26G and V45E, in the activator region, suggesting that the farnesylated C terminus and the activator region might cooperatively recognize CRD [15] . However, the molecular basis for this interaction remains elusive because of the difficulties in preparing posttranslationally modified Ras in an amount sufficient for structural studies by NMR and X-ray crystallography. In the present study, to address this problem, we make use of a protein ligation reaction catalyzed by a transpeptidase from Staphylococcus aureus, Sortase A (SrtA). SrtA cleaves a peptide bond between Thr and Gly in a recognition motif LPXTG attached to the donor (poly)peptides and executes a transpeptidation reaction between the resulting carboxyl group of Thr and an amino group of the N-terminal Gly attached to the acceptor (poly)peptides [19, 20] (Fig. S1B ). Accordingly, we are able to prepare H-Ras carrying various degrees of the modifications in amounts sufficient for structural studies by ligating between HRas 1-166 , attached with LPXTG, and the synthetic HVR peptides, attached with Gly and carrying chemical modifications equal to those in the cells (Table 1) . This procedure enables us to introduce stable isotope labeling into the residues 1-166 for structural analysis using NMR, and the results show that HVR makes an intramolecular interaction with a region of the catalytic domain encompassing the C terminus to the activator region across the central b sheet and that this interaction brings the farnesyl moiety to the vicinity of the activator region, which may be responsible for their cooperative recognition of c-Raf-1-CRD. Furthermore, we are able to solve the crystal structure of modified H-Ras for the first time, showing that the existence of modified HVR induces conformational changes of the a2-helix in Switch II, the C terminus of the a3-helix and the following loop. Since these regions were shown to be involved in the effector recognition, structural interconversion in the GTPbound form and the intrinsic GTP-hydrolyzing activity [4, [21] [22] [23] , the result suggests that the post-translational modifications may exert more global influence on the cellular function of Ras than previously thought. 
Materials and methods
Plasmids pFLAG-CMV2-H-Ras, an expression vector of FLAGtagged full-length H-Ras, was described before [24] . pFLAG-CMV2-H-Ras(LPKTG), where the residues 167-171 of H-Ras was replaced by LPTKG, was constructed by oligonucleotide-directed mutagenesis using In-Fusion HD Cloning System (Takara Bio USA, Mountain View, CA, USA). pGEX-6P-1-H-Ras and pQE-30 Xa-H-Ras were used for expression of H-Ras 1-166 as a glutathione-S-transferase (GST) fusion and with a 6 9 His tag, respectively, in Escherichia coli (E. coli) [25] . pGEX-6P-1-H-Ras substrate expressing GST-fusion H-Ras 1-166 attached with LPKTG and a 6 9 His tag at its C terminus was constructed by oligonucleotide-directed mutagenesis. pET28A-SSORA d59, an E. coli expression vector for SrtA attached with a Cterminal 6 9 His tag, was kindly provided by T. Yamazaki (Research Center for Functional Materials, National Institute for Materials Science, Tsukuba, Japan).
Antibodies
Rabbit anti-MEK (#9122), rabbit anti-phospho-MEK (Ser217/221; #9121), and rabbit anti-FLAG tag (#2368) antibodies (Abs) were obtained from Cell Signaling Technologies (Beverly, MA, USA). Rabbit anti-H-Ras C20 antibody (Ab; SC-520), raised against the C-terminal 20 residues of H-Ras, was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Goat anti-(rabbit IgG) Ab was obtained from GE Healthcare (Buckinghamshire, UK).
Synthetic HVR peptides
Peptides with various degrees of the modifications, which correspond to the residues 172 to the C termini of H-Ras, carry amino acid substitutions of Ser for Cys181 and Cys184 and are added with the SrtA recognition signal Gly at their N termini (Table 1) , were synthesized and obtained from Peptide Institute, Inc. (Osaka, Japan). The authenticity of the peptides was confirmed by mass spectrometric analyses.
Cell culture and transfection
Human embryonic kidney AD293 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% FBS, penicillin and streptomycin, and transfected with the expression vectors using Lipofectamine 2000 (ThermoFisher Scientific, Waltham, MA, USA). In 20-24 h after transfection, cells were lysed in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol (DTT), phosphatase inhibitor cocktail (Nacalai Tesque, Kyoto, Japan), and protease inhibitor cocktail (Nacalai Tesque), and, after centrifugation at 1000 g for 20 min, the resulting supernatant was subjected to western blotting. Protein concentration was determined by Quick Start Bradford Reagent (BIO-RAD, Hercules, CA, USA).
Western blotting
Proteins were separated by standard SDS/PAGE and transferred onto PVDF membranes. The membrane was probed by an appropriate primary Ab, followed by a horse radish peroxidase-conjugated goat anti-(rabbit IgG) Ab. The immunoreactive signals were developed with ImmunoStar Zerta (Wako Pure Chemicals, Osaka, Japan) and detected by using ImageQuant LAS 4000 mini (GE Healthcare).
Protein production and purification N and 13 C was performed as described before [23] . The cells were disrupted by sonication in buffer A (50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 150 mM NaCl, 10 mM MgCl 2 , 1 mM DTT, and 0.01% Triton X-100) and, after centrifugation at 30 000 g for 20 min, GST-fusion H-Ras and H-Ras substate were purified from the resulting supernatant by absorption onto glutathione-Sepharose 4B resin (GE Healthcare) and elution by on-column cleavage with Turbo3C protease (Accelagen, San Diego, CA, USA) [23] . 6 9 His-tagged H-Ras was purified by absorption onto Ni-nitrilotriacetic acid resin (QIAGEN, Chatsworth, CA, USA) and elution with 100 mM imidazole. The eluted Ras proteins were further purified by HiTrap Q HP column chromatography (GE Healthcare) and subsequently loaded with a nonhydrolyzable GTP analog, guanosine 5 0 -(b,c-imido) triphosphate (GppNHp) [25] .
Production of H-Ras•GppNHp carrying various degrees of the modifications
Sortase A and H-Ras substrate produced in E. coli were separately immobilized on Ni-nitrilotriacetic acid agarose resin (QIAGEN). Subsequently, the SrtA-immobilized resin, the H-Ras substrate -immobilized resin and the synthetic HVR peptides were mixed together at the protein/peptide molar ratio of 1 : 8 : 10 and incubated at 30°C for 24 h in the presence of 500 lM GDP and 20 mM CaCl 2 . The resulting ligation products were then eluted by washing the resin with buffer A, loaded with GppNHp and immobilized on glutathione-Sepharose 4B resin. After washing with 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10 mM MgCl 2 , 1 mM DTT, and 3.4 mM n-Octyl-b-D-glucoside (n-OG), H-Ras was eluted by cleavage with Turbo3C protease.
Mass spectrometric analyses
The ligation products were analyzed by matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS). After desalting and removal of detergent by using ZipTip SCX (Millipore, Billerica, MA, USA), 2.5 lL of the sample solution was co-crystallized with matrix (20 mgÁmL À1 2, 5-dihydroxybenzonic acid in 30% acetonitrile and 0.1% trifluoroacetic acid) on a target plate at room temperature, and the spectra were acquired on a Bruker UltraFlex III instrument in the linear positive mode. The calibration was done by using Protein standard II (Bruker Daltonics, Billerica, MA, USA).
Surface plasmon resonance (SPR) analysis
Binding of the HVR peptides to H-Ras 1-166 was measured by using Biacore T200 (GE Healthcare). 6 9 His-tagged HRas 1-166 •GppNHp was immobilized on an nitrilotriacetic acid sensor chip to the density of~2500 RU. The HVR peptides were introduced at 25°C with a flow rate of 30 lLÁmin À1 in a running buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 0.05 mM EDTA, and 0.05% Tween-20) with a contact time of 2 min. The difference in the sensorgram between the blank flow cell and the protein-immobilized flow cell was used for the binding analysis.
NMR spectroscopy
The NMR spectra were recorded on a Bruker AVANCE III 600 instrument equipped with shielded gradient triple-resonance probes in NMR measurement buffer (25 mM phosphate buffer, pH 6.8, 50 mM NaCl, 10 mM MgCl 2 , 1 mM DTT, and 3.4 mM n-OG) containing 10% (v/v) D 2 O at 298 K and analyzed by using NMRPipe [26] and NMRView (One Moon Scientific, Westfield, NJ, USA 3K8Y ] as a search model. The structural refinement and the interactive rebuilding process were carried out by the programs Refmac [30] and Coot [31] , respectively. Data collection and refinement statistics are listed in Table 2 . The R sym value became slightly high depending on the quality of the crystal. The atomic coordinate has been deposited in the PDB (http://www.rcsb.org) under the accession code 5X9S. , and H-Ras
, by the SrtA-catalyzed ligation of bacterially expressed H-Ras substrate with the corresponding synthetic HVR peptides (Table 1) . Optimization study of the reaction condition showed that the highest yield of the ligation products was obtained when the reaction was carried out at 30°C for 24 h at the molecular ratio of 1 : 8 : 10 for H-Ras (Fig. 1A) and could be detected by anti-H-Ras C20 Ab (Fig. 1B) , indicating the completion of the ligation reaction. Moreover, when the purified H-Ras , and H-Ras C(Far)OMe were subjected to MALDI-TOF-MS analysis, the estimated molecular masses of their major components matched well with those predicted from their chemical formulas. In the ligation products, the residues 167-171 of HVR were replaced by LPTKG. To examine the effect of this replacement on the cellular activity, we expressed H-Ras and H-Ras(LPKTG), both carrying an activating mutation G12V to get rid of the influence of upstream regulatory factors, in AD293 cells and observed no detectable difference in the ability to induce MEK activation (Fig. 1C) . These results strongly suggested that the ligation products were the functional equivalents of the genuine H-Ras proteins. N HSQC spectra, which were simplified due to the absence of the NH signals arising from the HVR residues. The spectra of both HRas CVLS •GppNHp and H-Ras C(Far)OMe •GppNHp displayed well-dispersed cross-peaks, indicating that the proteins were stably folded (Fig. S2A,B) . Signal assignments for the two proteins were achieved with reference to the data on H-Ras substrate •GppNHp in which 136 residues out of 163 non-Pro residues were assigned. Unassigned residues with severely broadened signals were mainly located in the regions including Switch I and Switch II, which underwent interconversion between two conformational states on a millisecond time scale [32] . Spectral comparison between HRas CVLS •GppNHp and H-Ras substrate
•GppNHp revealed that a number of signals exhibited significant chemical shift perturbations and that their corresponding residues were mainly located in the region encompassing the C terminus (Ile163-Gln165) to the activator The purified ligation products were subjected to western blotting using anti-H-Ras C20 Ab. (C) AD293 cells were transfected with either pFLAG-CMV2-HRasG12V(LPKTG) [G12V(LPKTG)], pFLAG-CMV2-H-RasG12V (G12V), pFLAG-CMV2-H-Ras (WT) or pFLAG-CMV2 (Vector), and the lysate of the cells was fractionated by SDS/PAGE (15% gel) and subjected to western blotting using anti-phospho-MEK (pMEK), anti-MEK (tMEK) and anti-FLAG tag (FLAG) Abs.
region (His27, Val44, Val45, and Glu49) across the central b sheet (Thr2, Lys5, and Leu6 in the b1-strand and Cys51-Leu53 in the b3-strand; Fig. 2A (Fig. 2C) . However, it showed additional chemical shift perturbations or severe signal broadening for the residues located in the activator region and its proximity, Phe28, Asp54, and Ile55, suggesting that the modified HVR carrying the farnesyl group was positioned in proximity to the distal part of the activator region (Figs 2A,D,E and S3 ). Among the residues exhibiting the signal changes in the 1 H-15 N HSQC spectra of H-Ras CVLS
•GppNHp and H-Ras C(Far)
OMe •GppNHp, Val8, Gly77, Phe78, Leu79, Phe156, and Val160 were buried in the hydrophobic core (Fig. 2E) . Therefore, it was likely that they were incapable of establishing any contacts with HVR and that the observed signal changes were attributed to either a secondary effect of the conformational change in the neighboring residues or the changes in their own conformational dynamics, or both of them.
To further prove the interaction of HVR with the catalytic domain, we analyzed the binding of the C (Far)OMe HVR peptide to H-Ras •GppNHp by 1 H- 15 N HSQC experiments. The result showed that Tyr40 in the activator region and the solvent-exposed residues, Ala66, Gln70, and Thr74, in the a2-helix exhibited significant chemical shift perturbations (Fig. 3) . Taken together, these results strongly suggested that the farnesyl moiety is positioned in the proximity of the activator region via the intramolecular interaction between HVR and the catalytic domain. Consistent with the NMR data, surface plasmon resonance (SPR) analyses showed that the CFarOMe HVR peptide exhibited dose-dependent binding to HRas •GppNHp at the concentrations ranging from 0.5 to 2.0 mM (Fig. S4) . The observed response values seemed too high considering the molecular weight of the CFarOMe HVR peptide, however, this could be accounted for by association of a Tween-20 micelle with the peptide in the running buffer. The CVLS HVR peptide showed weaker binding barely detectable at the concentration of 4 mM, indicating that the modifications had a facilitative effect on the interaction.
Crystal structure of modified H-Ras and its structural differences from unmodified H-Ras
We successfully determined the crystal structure of HRas C(Far)OMe •GppNHp for the first time at the resolution of 2.5 A. No electron density corresponding to the modified HVR was observed, suggesting that its structure was heavily disordered. Data collection and refinement statistics are listed in Table 2 . The overall structure of the catalytic domain was similar to that of H-Ras •GppNHp (PDB code 3K8Y). Superimposition of the two structures indicated that a large part of the a2-helix in Switch II was unstructured and that the C-terminal part of the a3-helix and the following loop were shifted toward the a2-helix (Fig. 4A,B) . These regions were known to adopt variable conformations with functional relevance as found in the active and inactive states of Ras•GTP and the complexes with Sos and PI3Kc [4, 22] (Fig. 4C, see Discussion) . The conformational changes agreed well with the NMR data in that the residues in the corresponding region: Ala66, Met67, Arg68, Thr74, and Gly75 in the a2-helix and Lys104 in the a3-helix, showed significant signal changes in (Fig. 2C ,E) although we cannot exclude the possibility that they were contributed by the crystal packing effect. In the crystal structure, Val8, Gly77, Phe78, Leu79, and Val81, which exhibited the HSQC signal perturbations despite their location in the hydrophobic core, were found to be located adjacent to the regions showing the conformational changes, proving that their HSQC signal changes were likely to be ascribable to the secondary effect of the conformational changes in the neighboring regions.
Discussion
Although Ras proteins exert their cellular functions as the post-translationally modified form, their structural studies had been regularly carried out using the unmodified form often truncated with HVR. One of its major reasons was the problem of tremendous difficulties in preparation of modified Ras in an amount sufficient for structural studies by NMR and X-ray crystallography. In the present study, we addressed this problem by the adoption of the SrtA-catalyzed protein ligation. Moreover, the method enabled us to systematically produce modified Ras proteins representing various stages of the post-translational modifications and to introduce stable isotope labeling into the catalytic domain for NMR analysis. Actually, the SrtA-catalyzed ligation reaction had been employed to produce a similar of modified K-Ras4B, however, a sulfo-SMCC cross-linking agent was used to attach the farnesylated and carboxymethylated Cys to the C terminus and the product was not functionally characterized in detail [33] . Recently, Gillette et al. [34] reported high yield production of fully modified K-Ras4B using an improved insect cell expression system, which will certainly facilitate the structural study on modified Ras. By comparison, our method has the advantage of making possible the analysis of the role of the individual modification steps and the labeling of the products by stable isotopes or other means.
In this study, we have demonstrated the existence of an intramolecular interaction of the modified HVR with the catalytic domain of H-Ras•GppNHp and clarified its molecular basis by comparison of the NMR spectra among H-Ras substrate •GppNHp, HRas CVLS •GppNHp and H-Ras C(Far)OMe •GppNHp and of the crystal structures between H-Ras 1-166 •GppNHp and H-Ras C(Far)OMe •GppNHp. Moreover, the interaction was further supported by the binding experiment of the C(Far)OMe HVR peptide to the catalytic domain by using NMR and SPR. The results showed that HVR interacts intramolecularly with a region of the catalytic domain encompassing the C terminus to the activator region across the central b sheet and that this causes positioning of the modified HVR carrying the farnesyl group in proximity to the distal part of the activator region. The observations that a millimolar concentration of the C(Far)OMe HVR peptide was required for the detection of its binding to H-Ras •GppNHp in both NMR and SPR and that the modified HVR was completely disordered in the crystal structure of H-Ras C(Far)OMe •GppNHp suggest the low-affinity and transient nature of their intramolecular interaction, although the low affinity observed for the peptide-protein binding could be compensated to some extent by the covalent attachment of HVR to the C terminus of the catalytic domain. The functional significance of this low-affinity intramolecular interaction remains to be clarified further, particularly with regard to how it is compatible with the interaction of the farnesyl moiety with membrane lipids and trafficking/scaffolding proteins such as PDEd and Galectin [35] [36] [37] [38] . Also, the SPR analyses showed that the post-translational modifications strengthened the binding of the HVR peptide to HRas •GppNHp (Fig. S4 ), suggesting that they might stabilize the intramolecular interaction. These results supported the notion by Thapar et al. [39] suggesting the existence of a weak interaction between the farnesyl moiety and the hydrophobic residues on the activator region, Phe28 and Val29, as one interpretation for their NMR data. In the case of K-Ras4B, the interaction of the unmodified HVR with the catalytic domain had been observed, which seemed to be mediated by an electrostatic interaction contributed by the polybasic region of HVR [40] . It must be noted that the protein ligation resulted in the replacement of the residues 167-171 in HVR with LPTKG. Thapar et al. [39] had reported that the region encompassing these residues was intrinsically unstable but exhibited a propensity for adopting an a-helical structure, raising a possibility that the replacement might alter the flexibility of HVR thereby affecting its intramolecular interaction with H-Ras . Although we cannot fully exclude this possibility, the absence of the effect on the cellular activity of Ras to activate c-Raf-1 (Fig. 1C) implies that the replacement is unlikely to have a significant effect on the structure and function of Ras.
The molecular mechanism for the cellular activation of c-Raf-1 by modified Ras•GTP involves complex processes including membrane recruitment, phosphorylations, protein-protein interactions including dimerization and resulting conformational changes, the whole picture of which still remains to be clarified [41] . Previous studies had indicated that Ras directly binds to c-Raf-1-CRD and that this interaction is necessary for the full activation of c-Raf-1 and dependent on the farnesylation and the activator region of Ras [11, [15] [16] [17] [18] , suggesting that the farnesylated C terminus and the activator region might cooperatively recognize CRD. Consistent with this, an NMR study using H-Ras•GDP, which was modified by in vitro adopt a compact tertiary structure where the farnesylated HVR is arranged in close proximity to the activator region, which may form a molecular basis for their cooperative binding to CRD (Fig. S5) . The farnesyl moiety might contribute to a hydrophobic interaction between Ras and CRD and, in that case, the carboxymethylation of Cys186 might serve to strengthen this interaction as observed for the interaction between farnesylated K-Ras4B and PDEd, where the binding affinity became approximately two orders of magnitude higher depending on the carboxymethylation [42] . In this line, biochemical and structural characterization of H-Ras C(Far)VLS and H-Ras
may provide further insight into the significance of the carboxymethylation as well as the AAX removal. The functional significance of the Ras-c-Raf-1-CRD interaction remains to be clarified further, particularly with regard to how it is compatible with the interaction of the farnesyl moiety with membrane lipids and trafficking/scaffolding proteins such as PDEd and Galectin [35] [36] [37] [38] . The role of the farnesyl moiety in the plasma membrane localization would be compensated by the palmitoylation in H-Ras, N-Ras, and K-Ras4A and by the polybasic region in K-Ras4B. The crystal structure of H-Ras C(Far)OMe
•GppNHp revealed that the a2-and a3-helices adopted local structures distinct from those of H-Ras •GppNHp.
Because the a2-and a3-helices are known to undergo diverse conformational changes in association with a wide range of the physiological functions, such as the recognition of the effector molecules, the intrinsic GTP hydrolysis and the structural interconversion between the inactive and active states of Ras•GTP [4, [21] [22] [23] (Fig. 4C) , the post-translational modifications may significantly affect the biophysical and biochemical parameters of Ras proteins relevant to their cellular functions. Since such parameters have regularly been determined using unmodified Ras often truncated with HVR, they must be critically examined using the post-translationally modified form.
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